These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36437024)

  • 21. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.
    Bunchorntavakul C; Reddy KR
    Aliment Pharmacol Ther; 2020 Jan; 51(1):64-77. PubMed ID: 31701570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis.
    Tsien CD; McCullough AJ; Dasarathy S
    J Gastroenterol Hepatol; 2012 Mar; 27(3):430-41. PubMed ID: 22004479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Branched-Chain Amino Acids as a Potential Treatment for Improving Nutrition-Related Outcomes in Advanced Chronic Liver Disease.
    Colosimo S; Bertoli S; Saffioti F
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
    Hernández-Conde M; Llop E; Gómez-Pimpollo L; Fernández Carrillo C; Rodríguez L; Van Den Brule E; Perelló C; López-Gómez M; Abad J; Martínez-Porras JL; Fernández-Puga N; Ferre C; Trapero M; Fraga E; Calleja JL
    Am J Gastroenterol; 2021 Nov; 116(11):2241-2249. PubMed ID: 34074812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nutritional Assessment and Management for Patients with Chronic Liver Disease].
    Lee TH
    Korean J Gastroenterol; 2018 Apr; 71(4):185-191. PubMed ID: 29684966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutritional treatment with branched-chain amino acids in advanced liver cirrhosis.
    Marchesini G; Bianchi G; Rossi B; Brizi M; Melchionda N
    J Gastroenterol; 2000; 35 Suppl 12():7-12. PubMed ID: 10779207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcopenia in cirrhosis: from pathogenesis to interventions.
    Ebadi M; Bhanji RA; Mazurak VC; Montano-Loza AJ
    J Gastroenterol; 2019 Oct; 54(10):845-859. PubMed ID: 31392488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.
    Kim HY; Jang JW
    World J Gastroenterol; 2015 Jul; 21(25):7637-47. PubMed ID: 26167066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malnourished cirrhotic patient: what should we do?
    Sciarrone SS; Zanetto A; Russo FP; Germani G; Gambato M; Battistella S; Pellone M; Shalaby S; Burra P; Senzolo M
    Minerva Gastroenterol (Torino); 2021 Mar; 67(1):11-22. PubMed ID: 33784807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-Evening Carbohydrate and Branched-Chain Amino Acid Snacks Improve the Nutritional Status of Patients Undergoing Hepatectomy Based on Bioelectrical Impedance Analysis of Body Composition.
    Kobayashi K; Kaneko J; Yamaguchi T; Kawaguchi Y; Arita J; Akamatsu N; Ishizawa T; Sekine R; Ijichi H; Kubota N; Fukatsu K; Kokudo N; Hasegawa K
    Gastrointest Tumors; 2019 Oct; 6(3-4):81-91. PubMed ID: 31768352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early administration of branched-chain amino acid granules.
    Ishikawa T
    World J Gastroenterol; 2012 Sep; 18(33):4486-90. PubMed ID: 22969221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver.
    Di Cola S; Khan S; Lapenna L; Merli M
    Expert Opin Emerg Drugs; 2024 Jun; 29(2):81-91. PubMed ID: 38549232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional Evaluation and Treatment of the Cirrhotic Patient.
    Zelber-Sagi S; Ivancovsky-Wajcman D; Rabinowich L; Bentov I; Deutsch L
    Clin Liver Dis; 2021 May; 25(2):373-392. PubMed ID: 33838856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary management and supplementation with branched-chain amino acids in cirrhosis of the liver.
    Ruiz-Margáin A; Méndez-Guerrero O; Román-Calleja BM; González-Rodríguez S; Fernández-Del-Rivero G; Rodríguez-Córdova PA; Torre A; Macías-Rodríguez RU
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):424-433. PubMed ID: 30292583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can L-carnitine supplementation and exercise improve muscle complications in patients with liver cirrhosis who receive branched-chain amino acid supplementation?
    Hiraoka A; Kiguchi D; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):878-884. PubMed ID: 31150367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in the treatment of sarcopenia in patients with cirrhosis].
    Zhang JT; Kong M; Geng N; Lin N; Chen Y; Duan ZP
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1340-1344. PubMed ID: 38253082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based clinical practice guidelines for liver cirrhosis 2015.
    Fukui H; Saito H; Ueno Y; Uto H; Obara K; Sakaida I; Shibuya A; Seike M; Nagoshi S; Segawa M; Tsubouchi H; Moriwaki H; Kato A; Hashimoto E; Michitaka K; Murawaki T; Sugano K; Watanabe M; Shimosegawa T
    J Gastroenterol; 2016 Jul; 51(7):629-50. PubMed ID: 27246107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis.
    Ruiz-Margáin A; Macías-Rodríguez RU; Ríos-Torres SL; Román-Calleja BM; Méndez-Guerrero O; Rodríguez-Córdova P; Torre A
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):9-15. PubMed ID: 28408059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Protein catabolism and malnutrition in liver cirrhosis - impact of oral nutritional therapy].
    Norman K; Valentini L; Lochs H; Pirlich M
    Z Gastroenterol; 2010 Jul; 48(7):763-70. PubMed ID: 20607635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
    Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.